FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Exela Pharma Sciences 8.4% Sodium Bicarbonate Injection Recall

8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose…

Exela Pharma Sciences LLC · Lenoir, NC

Risk level
Class II
Reported by FDA
Apr 2, 2025
Recall ID
D-0303-2025
Check your lot numberHow we source this data

Summary

Exela Pharma Sciences recalled 8.4% Sodium Bicarbonate Injection starting Mar 7, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0303-2025 on Apr 2, 2025. Reason: Lack of Assurance of Sterility. Status: Ongoing.

Why it was recalled

Lack of Assurance of Sterility

Product description

8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose Vials per carton, For Intravenous Use Only, Rx Only, Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645. NDC Inner Vial: 51754-5001-1; NDC Carton: 51754-5001-4

Lot numbers, UPCs & expiration codes

Lots: 10006417 and 10006418, Exp. 11/30/2026

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0303-2025
Classification
Class II
Status
Ongoing
Recall initiated
Mar 7, 2025
FDA report date
Apr 2, 2025
Quantity
103,950 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Exela Pharma Sciences LLC

Original FDA data

Every field from FDA enforcement report D-0303-2025, exactly as published.

Show all FDA fields
City
Lenoir
State
NC
Status
Ongoing
Country
United States
Event ID
96481
Address
1245 Blowing Rock Blvd
Code information
Lots: 10006417 and 10006418, Exp. 11/30/2026
Postal code
28645-3618
Report date
Apr 2, 2025
Product type
Drugs
Recall number
D-0303-2025
Classification
Class II
Recalling firm
Exela Pharma Sciences LLC
Product quantity
103,950 vials
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose Vials per carton, For Intravenous Use Only, Rx Only, Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645. NDC Inner Vial: 51754-5001-1; NDC Carton: 51754-5001-4
Distribution pattern
Nationwide
Recall initiation date
Mar 7, 2025
Initial firm notification
Letter
Center classification date
Mar 27, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0303-2025, published Apr 2, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls